Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Asset Utilization Ratio (2018 - 2026)

Sol-Gel Technologies (SLGL) posted quarterly Asset Utilization Ratio of 0.42 for Q1 2026, up 8.49% year-over-year from 0.38 in Q1 2025, and down 30.55% quarter-over-quarter from 0.6 in Q4 2025.

Analysis

Sol-Gel Technologies (SLGL) Asset Utilization Ratio (2018 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Asset Utilization Ratio for 9 consecutive years, with 0.42 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Asset Utilization Ratio rose 8.49% year-over-year to 0.42; the TTM figure through Mar 2026 stood at 0.42 (up 8.49% YoY), while the FY2025 annual figure was 0.59, up 107.31% from the prior year.
  • Asset Utilization Ratio declined to 0.42 in Q1 2026 per SLGL's latest filing, from 0.6 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 61.36 in Q4 2022 and bottomed at 0.02 in Q3 2023.
  • Historically, Asset Utilization Ratio has averaged 14.97 across 5 years, with a median of 0.42 in 2026.
  • Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 56136.96% — and 2023, when it slumped 99.96%.
  • Sol-Gel Technologies' Asset Utilization Ratio stood at 61.36 in 2022, then plunged by 99.95% to 0.03 in 2023, then surged by 926.91% to 0.29 in 2024, then surged by 105.67% to 0.6 in 2025, then slumped by 30.55% to 0.42 in 2026.
  • Business Quant data shows SLGL's Asset Utilization Ratio at 0.42 in Q1 2026, 0.6 in Q4 2025, and 0.51 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 0.38
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 0.20
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 0.69
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 0.90
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.13
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.54
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn - 0.03
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.03
Mar 31, 2026 0.42
Dec 31, 2025 0.60
Sep 30, 2025 0.51
Jun 30, 2025 0.72
Mar 31, 2025 0.38
Dec 31, 2024 0.29
Sep 30, 2024 0.28
Jun 30, 2024 0.16
Mar 31, 2024 0.04
Dec 31, 2023 0.03
Sep 30, 2023 0.02
Jun 30, 2023 0.02
Mar 31, 2023 0.09
Dec 31, 2022 0.08
Sep 30, 2022 0.46
Jun 30, 2022 0.46
Mar 31, 2022 0.37
Dec 31, 2021 0.39
Sep 30, 2021 0.10